| Companies sponsors |
Amgen Ltd (blinatumomab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Leukaemia Care |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
Accord UK Ltd (cytarabine, doxorubicin, etoposide, methotrexate) (confidentiality agreement not signed, not participating) |
| |
ADVANZ Pharma (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Almus Pharmaceuticals Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Aspen Pharma Trading Ltd (mercaptopurine) (confidentiality agreement not signed, not participating) |
| |
Baxter Healthcare Ltd (doxorubicin, cyclophosphamide) (confidentiality agreement not signed, not participating) |
| |
Cipla EU Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Consilient Health Ltd (etoposide) (confidentiality agreement not signed, not participating) |
| |
Esteve Pharmaceuticals Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Fontus Health Ltd (mercaptopurine) (confidentiality agreement not signed, not participating) |
| |
Fresenius Kabi Ltd (etoposide) (confidentiality agreement not signed, not participating) |
| |
Hospira UK Ltd (cytarabine, methotrexate, vincristine) (confidentiality agreement not signed, not participating) |
| |
Jazz Pharmaceuticals UK (cytarabine, daunorubicin) (confidentiality agreement not signed, not participating) |
| |
medac GmbH (asparaginase, doxorubicin, etoposide, methotrexate) (confidentiality agreement not signed, not participating) |
| |
Medihealth (Northern) Ltd (mercaptopurine, methotrexate) (confidentiality agreement not signed, not participating) |
| |
Morningside Healthcare Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Neon Healthcare Ltd (etoposide) (confidentiality agreement not signed, not participating) |
| |
Nordic Pharma Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Nova Laboratories Ltd (mercaptopurine) (confidentiality agreement not signed, not participating) |
| |
Orion Pharma (UK) Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Pfizer Ltd (cytarabine, doxorubicin, methotrexate, vincristine) (confidentiality agreement not signed, not participating) |
| |
Rosemont Pharmaceuticals Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Sandoz Ltd (cyclophosphamide, methotrexate) (confidentiality agreement not signed, not participating) |
| |
Seacross Pharmaceuticals Ltd (doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Sigma Pharmaceuticals Plc (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Teva Ltd (methotrexate, vincristine) (confidentiality agreement not signed, not participating) |
| |
Therakind Ltd (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Zentiva Pharma UK Ltd (daunorubicin) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |